Oral magnesium supplementation in insulin-requiring Type 2 diabetic patients

Diabetic Medicine : a Journal of the British Diabetic Association
H W de ValkA Struyvenberg

Abstract

Oral magnesium (Mg) supplementation can improve insulin sensitivity and secretion in patients with Type 2 diabetes mellitus (DM). We studied the effect of Mg supplementation on glycaemic control, blood pressure, and plasma lipids in insulin-requiring patients with Type 2 DM. Fifty moderately controlled patients were randomized to 15 mmol Mg or placebo daily for 3 months. Plasma Mg, glucose, HbA1c, lipids, erythrocyte Mg, Mg and glucose concentrations in 24-h urine, and systolic and diastolic pressure were measured before and after 3 months treatment. Plasma Mg concentration was higher after supplementation than after placebo (0.82 +/- 0.07 vs 0.78 +/- 0.08 mmol l(-1), p < 0.05), as was Mg excretion (5.5 +/- 1.9 vs 3.7 +/- 1.4 mmol 24 h(-1), p = 0.004) but erythrocyte Mg concentrations were similar. No significant differences were found in glycaemic control (glucose: 10.7 +/- 3.8 vs 11.6 +/- 6.2 mmol l(-1), p = 0.8; HbA1c: 8.9 +/- 1.6 vs 9.1 +/- 1.2%, p = 0.8), lipids or blood pressure. On-treatment analysis (34 patients: 18 on Mg, 16 on placebo) yielded similar results. An increase in plasma Mg concentration irrespective of medication was associated with a tendency to a decrease in diastolic pressure (increased plasma Mg vs no ...Continue Reading

Citations

Feb 21, 2007·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Ryan BradleyLeanna J Standish
May 16, 2014·Canadian Journal of Diabetes·UNKNOWN Canadian Diabetes Association Clinical Practice Guidelines Expert CommitteeJeannette Goguen
Feb 13, 2007·European Journal of Pharmacology·Nepton SoltaniAhmad Reza Dehpour
Aug 8, 2007·Journal of the Cardiometabolic Syndrome·Mario Barbagallo, Ligia J Dominguez
Jul 25, 2007·Journal of Internal Medicine·S C Larsson, A Wolk
May 15, 2015·Diabetes, Obesity & Metabolism·Frank C Mooren
Nov 6, 2012·Clinica Chimica Acta; International Journal of Clinical Chemistry·Hassan Imran AfridiFarah Naz Talpur
Dec 25, 2003·Diabetes Care·Ruy Lopez-RidauraFrank B Hu
Dec 21, 2013·Diabetes Care·Alison B EvertWilliam S Yancy
Dec 21, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Oct 11, 2013·Diabetes Care·Alison B EvertUNKNOWN American Diabetes Association
Jun 23, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Luis E Simental-MendíaFernando Guerrero-Romero
Jun 1, 2005·Archives of Medical Research·Fernando Guerrero-Romero, Martha Rodríguez-Morán
Jun 11, 2008·Obesity Surgery·Hans-Erik JohanssonArvo Haenni
Aug 2, 2007·American Journal of Therapeutics·Mario BarbagalloLawrence M Resnick
Mar 4, 2005·Treatments in Endocrinology·Dominique Bonnefont-Rousselot
Apr 20, 2019·Diabetes Care·Alison B EvertWilliam S Yancy
Nov 4, 2010·Biological Trace Element Research·Chan Hee SongSun Myeong Ock
Feb 6, 2017·Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association·H Verma, R Garg
Sep 12, 2018·Nutrients·Jayme L WorkingerJonathan Bortz
Feb 10, 2017·European Journal of Clinical Pharmacology·Luis E Simental-MendíaFernando Guerrero-Romero
May 1, 2021·Nutrients·Mihnea-Alexandru GămanCamelia Cristina Diaconu
Nov 7, 2020·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Arvo Haenni, Inger Nilsen
Aug 28, 2021·Nutrients·Maria Letizia PetroniFederico Ravaioli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.